lrcx-20210728
false000070754900007075492021-07-282021-07-28
Table of Contents
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
 Current Report
Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934
Date of report (Date of earliest event reported): July 28, 2021
  LAM RESEARCH CORPORATION
(Exact name of registrant as specified in its charter)
 
Delaware 0-12933 94-2634797
(State or Other Jurisdiction
of Incorporation)
 (Commission
File Number)
 (IRS Employer
Identification Number)
4650 Cushing Parkway
Fremont, California 94538
(Address of principal executive offices including zip code)
(510572-0200
(Registrant’s telephone number, including area code)
Not Applicable
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act:
Title of each classTrading SymbolName of each exchange on which registered
Common Stock, Par Value $0.001 Per ShareLRCXThe Nasdaq Stock Market
(Nasdaq Global Select Market)
Indicate by check mark whether the registrant is an emerging growth company as defined in as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company     
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.                     


Table of Contents
Table of Contents
 
Item 2.02.  Results of Operations and Financial Condition 
Item 9.01.  Financial Statements and Exhibits 
SIGNATURES 
EX-99.1



Table of Contents
 Item 2.02.Results of Operations and Financial Condition
On July 28, 2021, Lam Research Corporation (the “Company”) issued a press release announcing its financial results for the fiscal quarter ended June 27, 2021, the text of which is attached hereto as Exhibit 99.1.
The information in this item of this Current Report on Form 8-K, including Exhibit 99.1, is furnished pursuant to Item 2.02 and shall not be deemed “filed” for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities under that Section. Furthermore, the information in this item of this Current Report on Form 8-K, including Exhibit 99.1, shall not be deemed to be incorporated by reference into the filings of the Company under the Securities Act of 1933, as amended, or the Exchange Act.
 Item 9.01.Financial Statements and Exhibits
(d) Exhibits
99.1



Table of Contents
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Date:July 28, 2021
LAM RESEARCH CORPORATION
(Registrant)
 /s/ Douglas R. Bettinger
 Douglas R. Bettinger
 Executive Vice President, Chief Financial Officer
 (Principal Financial Officer and Principal Accounting Officer)
 


Document

Exhibit 99.1
FOR IMMEDIATE RELEASE        
Lam Research Corporation Reports Financial Results for the Quarter Ended June 27, 2021
FREMONT, Calif., July 28, 2021 - Lam Research Corporation (the "Company," "Lam," "Lam Research") today announced financial results for the quarter ended June 27, 2021 (the “June 2021 quarter”).
Highlights for the June 2021 quarter were as follows:
Revenue of $4.15 billion.
U.S. GAAP gross margin of 46.2%, U.S. GAAP operating income as a percentage of revenue of 31.7%, and U.S. GAAP diluted EPS of $7.98.
Non-GAAP gross margin of 46.5%, non-GAAP operating income as a percentage of revenue of 32.6%, and non-GAAP diluted EPS of $8.09.
Key Financial Data for the Quarters Ended
June 27, 2021 and March 28, 2021
(in thousands, except per-share data, percentages, and basis points) 
U.S. GAAP
   June 2021March 2021Change Q/Q
Revenue  $4,145,179 $3,847,654 +8%
Gross margin as percentage of revenue  46.2 %46.3 %- 10 bps
Operating income as percentage of revenue  31.7 %31.1 %+ 60 bps
Diluted EPS  $7.98 $7.41 +8%
Non-GAAP
   June 2021March 2021Change Q/Q
Revenue  $4,145,179 $3,847,654 +8%
Gross margin as percentage of revenue  46.5 % 46.3 %+ 20 bps
Operating income as percentage of revenue  32.6 % 31.6 %+ 100 bps
Diluted EPS  $8.09  $7.49 +8%

U.S. GAAP Financial Results
For the June 2021 quarter, revenue was $4,145 million, gross margin was $1,915 million, or 46.2% of revenue, operating expenses were $599 million, operating income was 31.7% of revenue, and net income was $1,145 million, or $7.98 per diluted share on a U.S. GAAP basis. This compares to revenue of $3,848 million, gross margin of $1,780 million, or 46.3% of revenue, operating expenses of $585 million, operating income of 31.1% of revenue, and net income of $1,071 million, or $7.41 per diluted share, for the quarter ended March 28, 2021 (the “March 2021 quarter”).

Non-GAAP Financial Results
For the June 2021 quarter, non-GAAP gross margin was $1,926 million, or 46.5% of revenue, non-GAAP operating expenses were $574 million, non-GAAP operating income was 32.6% of revenue, and non-GAAP net income was $1,161 million, or $8.09 per diluted share. This compares to non-GAAP gross margin of $1,783 million, or 46.3% of revenue, non-GAAP operating expenses of $567 million, non-GAAP operating income of 31.6% of revenue, and non-GAAP net income of $1,084 million, or $7.49 per diluted share, for the March 2021 quarter.
“Lam continued its record performance in the June quarter, capping a fiscal 2021 with more than 45% revenue growth and an increase of over 70% in earnings per share,” said Tim Archer, Lam Research’s President and Chief Executive Officer. “The combination of strong semiconductor demand and rising device complexity is driving higher levels of wafer fabrication equipment investment. Our technology differentiation and deep collaboration with customers position Lam to extend our leadership across all market segments.”






Balance Sheet and Cash Flow Results
Cash and cash equivalents, short-term investments, and restricted cash and investments balances remained flat at $6.0 billion at the end of the June 2021 quarter compared to the end of the March 2021 quarter. Cash generated from operating activities totaling $1,435.9 million was offset by repayment of $822.0 million of borrowings; $431.3 million of share repurchases, including net share settlement on employee stock-based compensation; and $185.4 million of dividends paid to stockholders.
Revenue
The geographic distribution of revenue during the June 2021 quarter is shown in the following table:
RegionRevenue
China37%
Korea30%
Taiwan13%
Japan9%
United States5%
Southeast Asia3%
Europe3%
The following table presents revenue disaggregated between system and customer support-related revenue:
Three Months EndedTwelve Months Ended
June 27,
2021
March 28, 2021June 28,
2020
June 27,
2021
June 28,
2020
(In thousands)
Systems revenue$2,763,877 $2,545,306 $1,865,249 $9,764,845 $6,625,130 
Customer support-related revenue and other1,381,302 1,302,348 926,615 4,861,305 3,419,606 
$4,145,179 $3,847,654 $2,791,864 $14,626,150 $10,044,736 
System revenue includes sales of new leading-edge equipment in deposition, etch and clean markets.
Customer support-related revenue includes sales of customer service, spares, upgrades, and non-leading-edge equipment from our Reliant® product line.
Outlook
For the quarter ended September 26, 2021, Lam is providing the following guidance:
U.S. GAAPReconciling ItemsNon-GAAP
Revenue$4.3 Billion+/-$250 Million$4.3 Billion+/-$250 Million
Gross margin as a percentage of revenue46.0%+/-1%$Million46.0%+/-1%
Operating income as a percentage of revenue31.7%+/-1%$13 Million32.0%+/-1%
Net income per diluted share$8.02+/-$0.50$12 Million$8.10+/-$0.50
Diluted share count143 Million143 Million
The information provided above is only an estimate of what the Company believes is realizable as of the date of this release and does not incorporate the potential impact of any business combinations, asset acquisitions, divestitures, restructuring, balance sheet valuation adjustments, financing arrangements, gains or losses on equity investments, other investments, or other significant arrangements that may be completed or realized after the date of this release. U.S. GAAP to non-GAAP reconciling items provided include only those items that are known and can be estimated as of the date of this release. Actual results will vary from this model and the variations may be material. Reconciling items included above are as follows:
Gross margin as a percentage of revenue - amortization related to intangible assets acquired through business combinations, $1 million.
Operating income as a percentage of revenue - amortization related to intangible assets acquired through business combinations, $13 million.
Net income per diluted share - amortization related to intangible assets acquired though business combinations, $13 million; amortization of note discounts, $1 million; and associated tax benefit for non-GAAP items ($2 million); totaling $12 million.



Use of Non-GAAP Financial Results
In addition to U.S. GAAP results, this press release also contains non-GAAP financial results. The Company’s non-GAAP results for both the June 2021 and March 2021 quarters exclude amortization related to intangible assets acquired through business combinations, the effects of elective deferred compensation-related assets and liabilities, amortization of note discounts, and the income tax benefit of non-GAAP items. Additionally, the June 2021 quarter non-GAAP results exclude product rationalization charges.
Management uses non-GAAP gross margin, operating expense, operating income, operating income as a percentage of revenue, net income, and net income per diluted share to evaluate the Company’s operating and financial results. The Company believes the presentation of non-GAAP results is useful to investors for analyzing business trends and comparing performance to prior periods, along with enhancing investors’ ability to view the Company’s results from management’s perspective. Tables presenting reconciliations of non-GAAP results to U.S. GAAP results are included at the end of this press release and on the Company’s website at http://investor.lamresearch.com.
Caution Regarding Forward-Looking Statements
Statements made in this press release that are not of historical fact are forward-looking statements and are subject to the safe harbor provisions created by the Private Securities Litigation Reform Act of 1995. Such forward-looking statements relate to, but are not limited to: our outlook and guidance for future financial results, including revenue, gross margins, operating income and net income; the factors affecting wafer fabrication equipment investment or the future levels of such investment; the extent to which our technology is differentiated and the extent to which we will collaborate with customers; and our ability to maintain or extend our leadership across any or all market segments. Some factors that may affect these forward-looking statements include: the severity, magnitude and duration of the COVID–19 pandemic (and the related governmental, public health, business and community responses to it), and their impacts on our business, results of operations and financial condition, are evolving and are highly uncertain and unpredictable; business, political and/or regulatory conditions in the consumer electronics industry, the semiconductor industry and the overall economy may deteriorate or change; supply chain disruptions or manufacturing capacity constraints may limit our ability to manufacture and sell our products; the actions of our customers and competitors may be inconsistent with our expectations; trade regulations, export controls, trade disputes, and other geopolitical tensions may inhibit our ability to sell our products; and widespread outbreaks of illness may impact our operations and revenue in affected areas; as well as the other risks and uncertainties that are described in the documents filed or furnished by us with the Securities and Exchange Commission, including specifically the Risk Factors described in our annual report on Form 10–K for the fiscal year ended June 28, 2020, and our quarterly reports on Form 10–Q for the fiscal quarters ended September 27, 2020, December 27, 2020 and March 28, 2021. These uncertainties and changes could materially affect the forward-looking statements and cause actual results to vary from expectations in a material way. The Company undertakes no obligation to update the information or statements made in this release.

Lam Research Corporation is a global supplier of innovative wafer fabrication equipment and services to the semiconductor industry. As a trusted, collaborative partner to the world’s leading semiconductor companies, we combine superior systems engineering capability, technology leadership, and unwavering commitment to customer success to accelerate innovation through enhanced device performance. In fact, today, nearly every advanced chip is built with Lam technology. Lam Research (Nasdaq: LRCX) is a FORTUNE 500® company headquartered in Fremont, Calif., with operations around the globe. Learn more at www.lamresearch.com. (LRCX-F)
Consolidated Financial Tables Follow.
 ###





 
LAM RESEARCH CORPORATION
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
(in thousands, except per share data and percentages)
 Three Months EndedTwelve Months Ended
 June 27,
2021
March 28,
2021
June 28,
2020
June 27,
2021
June 28,
2020
(unaudited)(unaudited)(unaudited)(unaudited)(1)
Revenue$4,145,179 $3,847,654 $2,791,864 $14,626,150 $10,044,736 
Cost of goods sold2,229,978 2,067,523 1,511,532 7,820,844 5,436,043 
Gross margin1,915,201 1,780,131 1,280,332 6,805,306 4,608,693 
Gross margin as a percent of revenue46.2 %46.3 %45.9 %46.5 %45.9 %
Research and development381,749 381,120 338,810 1,493,408 1,252,412 
Selling, general and administrative217,525 203,703 185,800 829,875 682,479 
Total operating expenses599,274 584,823 524,610 2,323,283 1,934,891 
Operating income1,315,927 1,195,308 755,722 4,482,023 2,673,802 
Operating income as a percent of revenue31.7 %31.1 %27.1 %30.6 %26.6 %
Other expense, net(7,166)(35,320)(7,553)(111,219)(98,824)
Income before income taxes1,308,761 1,159,988 748,169 4,370,804 2,574,978 
Income tax expense(164,104)(88,867)(51,496)(462,346)(323,225)
Net income$1,144,657 $1,071,121 $696,673 $3,908,458 $2,251,753 
Net income per share:
Basic$8.02 $7.51 $4.79 $27.22 $15.55 
Diluted$7.98 $7.41 $4.73 $26.90 $15.10 
Number of shares used in per share calculations:
Basic142,662 142,676 145,295 143,609 144,814 
Diluted143,514 144,609 147,416 145,320 149,090 
Cash dividend declared per common share$1.30 $1.30 $1.15 $5.20 $4.60 
(1)Derived from audited financial statements.














 LAM RESEARCH CORPORATION
CONDENSED CONSOLIDATED BALANCE SHEETS
(in thousands)
 
June 27,
2021
March 28,
2021
June 28,
2020
(unaudited)(unaudited)(1)
ASSETS
Cash and cash equivalents$4,418,263 $3,673,366 $4,915,172 
Investments1,310,872 2,116,101 1,795,080 
Accounts receivable, net3,026,430 2,809,068 2,097,099 
Inventories2,689,294 2,552,032 1,900,024 
Prepaid expenses and other current assets207,528 171,703 146,160 
Total current assets11,652,387 11,322,270 10,853,535 
Property and equipment, net1,303,479 1,279,836 1,071,499 
Restricted cash and investments252,487 253,460 253,911 
Goodwill and intangible assets1,622,499 1,633,254 1,652,968 
Other assets1,061,300 796,093 727,134 
Total assets$15,892,152 $15,284,913 $14,559,047 
LIABILITIES AND STOCKHOLDERS’ EQUITY
Current portion of long-term debt and finance lease obligations$11,349 $825,434 $839,877 
Other current liabilities3,516,518 2,786,899 2,322,565 
Total current liabilities3,527,867 3,612,333 3,162,442 
Long-term debt and finance lease obligations4,990,333 4,991,613 4,970,848 
Income taxes payable948,037 924,629 909,709 
Other long-term liabilities398,727 381,505 332,559 
Total liabilities9,864,964 9,910,080 9,375,558 
Temporary equity, convertible notes— 3,217 10,995 
Stockholders’ equity (2)6,027,188 5,371,616 5,172,494 
Total liabilities and stockholders’ equity$15,892,152 $15,284,913 $14,559,047 
 
(1)Derived from audited financial statements.
(2)
Common shares issued and outstanding were 142,501 as of June 27, 2021, 142,607 as of March 28, 2021, and 145,331 as of June 28, 2020
 





 
LAM RESEARCH CORPORATION
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(in thousands)
 Three Months EndedTwelve Months Ended
 June 27,
2021
March 28,
2021
June 28,
2020
June 27,
2021
June 28,
2020
(unaudited)(unaudited)(unaudited)(unaudited)(1)
CASH FLOWS FROM OPERATING ACTIVITIES:
Net income1,144,657 1,071,121 696,673 3,908,458 2,251,753 
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization78,397 79,453 71,083 307,151 268,525 
Deferred income taxes(146,029)(1,136)(92,293)(151,477)(17,777)
Equity-based compensation expense56,321 55,746 53,153 220,164 189,197 
Other, net(27,786)(635)(9,493)(17,392)6,628 
Changes in operating assets and liabilities330,375 (39,469)93,925 (678,741)(571,875)
Net cash provided by operating activities1,435,935 1,165,080 813,048 3,588,163 2,126,451 
CASH FLOWS FROM INVESTING ACTIVITIES:
Capital expenditures and intangible assets(104,622)(89,596)(50,554)(349,096)(203,239)
Net sale (purchase) of available-for-sale securities799,965 233,529 (354,350)464,522 (15,000)
Other, net(6,282)(27,997)(25,305)(42,155)(25,845)
Net cash provided by (used for) investing activities689,061 115,936 (430,209)73,271 (244,084)
CASH FLOWS FROM FINANCING ACTIVITIES:
Proceeds from issuance of long-term debt, net of issuance costs— — 1,974,651 — 1,974,651 
Principal payments on debt(822,046)(16,245)(2,948)(862,060)(667,537)
Proceeds from borrowings on revolving credit facility— — — — 1,250,000 
Repayments of borrowings on revolving credit facility— — (1,250,000)— (1,250,000)
Treasury stock purchases(431,255)(1,094,571)(41,017)(2,697,704)(1,369,649)
Dividends paid(185,385)(186,551)(167,739)(726,992)(656,838)
Reissuance of treasury stock related to employee stock purchase plan56,330 — 46,992 97,764 85,439 
Proceeds from issuance of common stock851 9,626 1,869 24,123 8,084 
Other, net(269)(665)1,592 (2,113)1,920 
Net cash (used for) provided by financing activities(1,381,774)(1,288,406)563,400 (4,166,982)(623,930)
Effect of exchange rate changes on cash, cash equivalents, and restricted cash702 (5,756)7,103 7,215 (2,750)
Net increase (decrease) in cash, cash equivalents, and restricted cash743,924 (13,146)953,342 (498,333)1,255,687 
Cash, cash equivalents, and restricted cash at beginning of period3,926,826 3,939,972 4,215,741 5,169,083 3,913,396 
Cash, cash equivalents, and restricted cash at end of period$4,670,750 $3,926,826 $5,169,083 $4,670,750 $5,169,083 
(1)Derived from audited financial statements.




 
Non-GAAP Financial Summary
(in thousands, except percentages and per share data)
(unaudited)
Three Months Ended
June 27,
2021
March 28,
2021
Revenue$4,145,179 $3,847,654 
Gross margin$1,926,323 $1,783,209 
Gross margin as percentage of revenue46.5 %46.3 %
Operating expenses$573,707 $566,507 
Operating income$1,352,616 $1,216,702 
Operating income as a percentage of revenue32.6 %31.6 %
Net income$1,161,211 $1,083,532 
Net income per diluted share$8.09 $7.49 
Shares used in per share calculation - diluted143,514 144,609 
Reconciliation of U.S. GAAP Net Income to Non-GAAP Net Income
(in thousands, except per share data)
(unaudited) 
Three Months Ended
June 27,
2021
March 28,
2021
U.S. GAAP net income$1,144,657 $1,071,121 
Pre-tax non-GAAP items:
Amortization related to intangible assets acquired through certain business combinations - cost of goods sold1,092 1,092 
Elective deferred compensation ("EDC") related liability valuation increase - cost of goods sold4,256 1,986 
Product rationalization - cost of goods sold5,774 — 
EDC related liability valuation increase - research and development7,661 3,575 
Product rationalization - research and development426 — 
Amortization related to intangible assets acquired through certain business combinations -selling, general and administrative12,357 12,357 
EDC related liability valuation increase - selling, general and administrative5,123 2,384 
Amortization of note discounts - other expense, net923 998 
Gain on EDC related asset - other expense, net(17,184)(7,520)
Net income tax benefit on non-GAAP items(3,874)(2,461)
Non-GAAP net income$1,161,211 $1,083,532 
Non-GAAP net income per diluted share$8.09 $7.49 
U.S. GAAP net income per diluted share$7.98 $7.41 
U.S. GAAP and non-GAAP number of shares used for per diluted share calculation143,514 144,609 




 
Reconciliation of U.S. GAAP Gross Margin, Operating Expenses and Operating Income to Non-GAAP Gross Margin, Operating Expenses and Operating Income
(in thousands, except percentages)
(unaudited) 
Three Months Ended
June 27,
2021
March 28,
2021
U.S. GAAP gross margin$1,915,201 $1,780,131 
Pre-tax non-GAAP items:
Amortization related to intangible assets acquired through certain business combinations1,092 1,092 
EDC related liability valuation increase4,256 1,986 
Product rationalization5,774 — 
Non-GAAP gross margin$1,926,323 $1,783,209 
U.S. GAAP gross margin as a percentage of revenue46.2 %46.3 %
Non-GAAP gross margin as a percentage of revenue46.5 %46.3 %
U.S. GAAP operating expenses$599,274 $584,823 
Pre-tax non-GAAP items:
Amortization related to intangible assets acquired through certain business combinations(12,357)(12,357)
EDC related liability valuation increase(12,784)(5,959)
Product rationalization(426)— 
Non-GAAP operating expenses$573,707 $566,507 
U.S. GAAP operating income$1,315,927 $1,195,308 
Non-GAAP operating income$1,352,616 $1,216,702 
U.S. GAAP operating income as percent of revenue31.7 %31.1 %
Non-GAAP operating income as a percent of revenue32.6 %31.6 %
 
Lam Research Corporation Contact:
Tina Correia, Investor Relations, phone: 510-572-1615, e-mail: investor.relations@lamresearch.com